scriptaid has been researched along with Benign Neoplasms in 2 studies
scriptide: provokes translocation of GLUT4 to increase glucose uptake; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Scriptaid treatment enhanced the spread of the P/V-CPI- virus through a population of cancer cells, and suppressed interferon-beta induction through blocking phosphorylation and nuclear translocation of Interferon Regulatory Factor 3 (IRF-3)." | 1.51 | Histone Deacetylase Inhibitors Enhance Cell Killing and Block Interferon-Beta Synthesis Elicited by Infection with an Oncolytic Parainfluenza Virus. ( Fox, CR; Parks, GD, 2019) |
| "Scriptaid is a well-tolerated and effective HDACi that reverses many of the functional and phenotypic properties of CAFs." | 1.48 | Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition. ( Barker, TH; Dudley, AC; Dunleavey, JM; Kim, DJ; Li, W; Ollila, DW; Otey, CA; Troester, MA; Xiao, L, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DJ | 1 |
| Dunleavey, JM | 1 |
| Xiao, L | 1 |
| Ollila, DW | 1 |
| Troester, MA | 1 |
| Otey, CA | 1 |
| Li, W | 1 |
| Barker, TH | 1 |
| Dudley, AC | 1 |
| Fox, CR | 1 |
| Parks, GD | 1 |
2 other studies available for scriptaid and Benign Neoplasms
| Article | Year |
|---|---|
Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition.
Topics: Animals; Cancer-Associated Fibroblasts; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cocul | 2018 |
Histone Deacetylase Inhibitors Enhance Cell Killing and Block Interferon-Beta Synthesis Elicited by Infection with an Oncolytic Parainfluenza Virus.
Topics: Caspases; Cell Line, Tumor; Histone Deacetylase Inhibitors; Humans; Hydroxylamines; Interferon Regul | 2019 |